Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production

This publication has 23 references indexed in Scilit:

• Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa
  Gut, 2000
• Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use
  PAIN®, 2000
• Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis
  JAMA, 1999
• COX-2 inhibitors
  The Lancet, 1999
• Rofecoxib
  Drugs, 1999
• Mechanism of Action of Nonsteroidal Anti-inflammatory Drugs
  Published by Elsevier ,1998
• Gastrointestinal Tract Complications of Nonsteroidal Anti-inflammatory Drug Treatment in Rheumatoid Arthritis
  Archives of internal medicine (1960), 1996
• Nonsteroidal anti-inflammatory drug-associated gastropathy: Incidence and risk factor models
  The American Journal of Medicine, 1991
• Non-steroidal anti-inflammatory drugs and peptic ulcers.
  BMJ, 1990
• Toward an Epidemiology of Gastropathy Associated With Nonsteroidal Antiinflammatory Drug Use
  Gastroenterology, 1989